Published on 23 February 2026
Description:
Special feature on GenAI and its impact on pharma – A focus on Rare Disease Day on 28 February – Top Five Most Studied Diseases report
Categories:
Pharmaceutical Market EuropePreview:
36 articles from this collection:
PME February 2026
2 COMMUNIQUE 2026
3 Comment
4 EHP AWARDS 2026
5 Contents
6 News
Roche and Ascidian agree to $1.8bn neurological disease partnership
7 News
8 News
Researchers identify new major cause of inflammatory bowel disease
9 News
10 DERMATOLOGY NEWS
11 DERMATOLOGY NEWS
12 Brian D Smith Darwin’s MEDICINE McNamara’s Fallacy
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
13 Mike Dixon With LIFELINE
14 MAXINE SMITH AND SIMON CAMPLING
15 HEALTHCARE: WHEN PATIENTS ASK AI FIRST: WHAT EMERGING AI HEALTH FEATURES MEAN FOR PHARMA
16-17 The world’s most studied diseases: four lessons from 2025
Across almost every sector, brands are multiplying their investment in creativity
18-19 Patient-centricity in rare disease: accelerating the path to treatment
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
20-22 Leading through turbulence
23 It’s time for an end to pharma exceptionalism
24 Flypharma Copenhagen 2026
25 GenAI in healthcare – friend or foe?
26 The ‘jagged frontier’, straight talk and why humans still matter
Picking your omnichannel direction requires a disciplined, scientific approach
27 AI-enabled, human-interpreted: the future of pharma marketing insights is precision intelligence
28-30 The race to explore and harness GenAI in healthcare
31 Pandemic readiness is now a financial risk test – and the UK must treat it that way
32 GenAI in healthcare: why privacy and literacy matter more than the tech
33 AI is quietly rewriting your brand narrative
34-36 GenAI: embracing the transformation – with caution
37 AI is quietly rewriting your brand narrative
38 How HCP Interact is advancing Medical Affairs performance with AI-enabled precision
39 Cuttsy+Cuttsy becomes employee-owned
40 Appointments
41 Appointments
42 Appointments
43 PMAWARDS
44 SAMEDAN
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services